Agilent Technologies vs Medline
Agilent Technologies (A), health care, and Medline (MDLN), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Medline is worth $49.6B on the stock market and Agilent Technologies $48.6B: Medline is valued at 2% more. Agilent Technologies trades at 34.0 times earnings and Medline at 85.6; operating margins in their latest fiscal years were 21.3% and 7.78%. Over the past year Agilent Technologies's share price has moved +20.2% and Medline's -4.46%.
Key facts
- Agilent Technologies market value
- $48.6B
- Medline market value
- $49.6B
- Agilent Technologies P/E
- 34.0
- Medline P/E
- 85.6
- Agilent Technologies revenue
- $6.9BFY to 2025-10-31
- Medline revenue
- $28.4BFY to 2025-12-31
- Superinvestors holding both
- 0
Market values as of .
| Measure | Agilent Technologies | Medline |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-10-31 | 2025-12-31 |
| Size | ||
| Market cap | $48.6Blower | $49.6Bhigher |
| Revenue | $6.9Blower | $28.4Bhigher |
| Earnings | $1.3Bhigher | $1.2Blower |
| Employees | 18,200lower | 45,000higher |
| Total assets | $12.7Blower | $38.5Bhigher |
| Valuation | ||
| P/E | 34.0lower | 85.6higher |
| P/S | 7.0higher | 1.7lower |
| P/B | 6.6higher | 2.8lower |
| Dividend yield | 0.59%higher | 0.00%lower |
| Profitability | ||
| Operating margin | 21.3%higher | 7.78%lower |
| Balance sheet | ||
| Net assets | $6.7Blower | $10.7Bhigher |
| Total liabilities | $6Blower | $19.2Bhigher |
| Total debt | $3.4Blower | $12.6Bhigher |
| Cash on hand | $1.8Blower | $1.9Bhigher |
| Price change | ||
| Today | -0.40%higher | -3.80%lower |
| 1 year | +20.2%higher | -4.46%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (0)
None of the tracked investors.
Agilent Technologies only (4)
- Larry Robbins5.2%
- Cliff Asness0.2%
- Primecap team0.1%
- Edgar Wachenheim<0.1%
Medline only (6)
- Stephen Mandel5.1%
- John Armitage4.7%
- Henry Ellenbogen1.0%
- Andreas Halvorsen0.5%
- George Soros0.5%
- Baillie Gifford team0.4%
Percentages are each holding's share of that investor's reported portfolio. Who owns A · Who owns MDLN
More on Agilent Technologies
Further comparisons
Agilent Technologies against its closest peers
Medline against its closest peers
Learn
Questions and answers
Which is bigger, Agilent Technologies or Medline?
By market value, Medline is the larger: $49.6B against $48.6B for Agilent Technologies. By revenue in its latest fiscal year, Medline is the larger: $28.4B against $6.9B for Agilent Technologies.
Which has the higher P/E ratio?
Medline: 85.6, against 34.0 for Agilent Technologies. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Agilent Technologies: 21.3%, against 7.78% for Medline. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has the higher dividend yield?
Agilent Technologies: 0.59%, against 0.00% for Medline. Dividend yield is the last twelve months' dividends as a share of today's share price.
Which has more debt?
Medline: $12.6B, against $3.4B for Agilent Technologies. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Agilent Technologies and Medline?
None of the tracked superinvestors holds both in their latest 13F filing. 4 hold Agilent Technologies and 6 hold Medline.
Cite this page
Funkfolio, “Agilent Technologies vs Medline”, data as of 17 November 2026. https://funkfolio.com/compare/a-vs-mdln
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.